​The global dihydromyricetin market was valued USD XX MN (by revenue) in 2022 The report foresees this market to reach USD XX MN by 2030 and register a CAGR of XX% from 2023 to 2030.
Dihydromyricetin is a heteroprotective flavonoid, which is extracted from Hovenia Dulcis. Dihydromyricetin is also known as Ampelopsin. It is used in traditional Chinese, Japanese medicine to treat flu, parasitic infection, liver diseases and for treating a hangover. Dihydromyricetin prevents intoxication, reduces alcohol addiction and shows anti-cancer activity.
Market Dynamics
Drivers:
- Rising demand from end-users
- Growing adoption of dihydromyricetin to reduce alcoholism
Restraints:
- Availability of substitute products
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter's five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of dihydromyricetin.
Market Segmentation
The broad dihydromyricetin market has been sub-grouped into application. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
By Type
By Application
- Pharma And Healthcare
- Food And Feed Additives
- Cosmetic And Personal Care
- Nutraceuticals
- Industrial Use
- Others
By Distribution Channel
Regional Analysis
Furthermore, the report comprises of the geographical segmentation, which mainly focuses on current and forecast demand for dihydromyricetin in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
Global Dihydromyricetin Market Size, Share Analysis Share by Region (Representative Graph)
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the dihydromyricetin market include Wuhan Vanz Pharm,Xian Sost Biotech, Wuhan Vanz Pharm, Xi'an Lyphar Biotech, Xi'an Natural Field Bio-Technique, Xian Tonking Biotech, Yongzhou Huamao Biotechnology, Xi'an Arisun ChemPharm. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.